Zhu X, Wang Y, Tao T, Li DP, Lan FF, Zhu W, Xie D, Kung HF. A new polymorphism in the GRP78 is not associated with HBV invasion. World J Gastroenterol 2009; 15(39): 4958-4961 [PMID: 19842229 DOI: 10.3748/wjg.15.4958]
Corresponding Author of This Article
Dan Xie, MD, PhD, State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, No. 651, Dongfeng Road East, Guangzhou 510060, Guangdong Province, China. xied@mail.sysu.edu.cn
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Zhu X, Wang Y, Tao T, Li DP, Lan FF, Zhu W, Xie D, Kung HF. A new polymorphism in the GRP78 is not associated with HBV invasion. World J Gastroenterol 2009; 15(39): 4958-4961 [PMID: 19842229 DOI: 10.3748/wjg.15.4958]
World J Gastroenterol. Oct 21, 2009; 15(39): 4958-4961 Published online Oct 21, 2009. doi: 10.3748/wjg.15.4958
A new polymorphism in the GRP78 is not associated with HBV invasion
Xiao Zhu, Yi Wang, Tao Tao, Dong-Pei Li, Fei-Fei Lan, Wei Zhu, Dan Xie, Hsiang-Fu Kung
Xiao Zhu, Institute of Oncology, Affiliated Tumor Hospital of Guangzhou Medical College, Guangzhou 510095, Guangdong Province, China
Xiao Zhu, Yi Wang, Wei Zhu, Dan Xie, Hsiang-Fu Kung, State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China
Tao Tao, Department of Digestive Diseases, Zibo Central Hospital, Zibo 255000, Shandong Province, China
Dong-Pei Li, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
Fei-Fei Lan, Laboratory of Integrated Biosciences, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, Guangdong Province, China
Author contributions: Zhu X performed the research and analyzed the data; Wang Y performed parts of the research and analyzed the data; Tao T coordinated the inclusion of subjects; Li DP and Zhu W wrote the manuscript; Lan FF analyzed the data; Xie D and Kung HF designed the research.
Supported by The grant from Ministry of Science and Technology of China, No. 2006CB910104; the Foundation of Guangzhou Science and Technology Bureau, the People’s Republic of China, No. 2005Z1-E0131
Correspondence to: Dan Xie, MD, PhD, State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, No. 651, Dongfeng Road East, Guangzhou 510060, Guangdong Province, China. xied@mail.sysu.edu.cn
Telephone: +86-20-87343193 Fax: +86-20-87343170
Received: July 27, 2009 Revised: August 28, 2009 Accepted: September 4, 2009 Published online: October 21, 2009
Abstract
AIM: To examine the association between -86 bp (T > A) in the glucose-regulated protein 78 gene (GRP78) and hepatitis B virus (HBV) invasion.
METHODS: DNA was genotyped for the single-nucleotide polymorphism by polymerase chain reaction followed by sequencing in a sample of 382 unrelated HBV carriers and a total of 350 sex- and age-matched healthy controls. Serological markers for HBV infection were determined by enzyme-linked immunosorbent assay kits or clinical chemistry testing.
RESULTS: The distributions of allelotype and genotype in cases were not significantly different from those in controls. In addition, our findings suggested that neither alanine aminotransferase/hepatitis B e antigen nor HBV-DNA were associated with the allele/genotype variation in HBV infected individuals.
CONCLUSION: -86 bp T > A polymorphism in GRP78 gene is not related to the clinical risk and acute exacerbation of HBV invasion.
